ANSWERS
Comprehensive Assessment
Year: 2026–2027 | Total Questions: 100 | 100% VERIFIED
Introduction
The Integrated Molecular and Diagnostic Pathology (IMDP) examination is a comprehensive
professional certification assessment designed to evaluate competency across the
molecular, cellular, and diagnostic sciences that underpin modern biomedical research and
clinical laboratory medicine. This question bank covers all key domains of the IMDP
certification blueprint: (1) Molecular Biology and Genetics, encompassing DNA replication,
the Central Dogma, mutations, PCR, epigenetics, gene editing (CRISPR-Cas9), sequencing
technologies (Sanger, NGS), FISH, and clinically significant chromosomal abnormalities; (2)
Cellular Physiology and Metabolism, addressing oxidative phosphorylation, apoptosis, the
Warburg effect, signal transduction, cell cycle regulation, autophagy, glycolysis, ROS, stem
cells, and membrane transport; (3) Immunology and Host Defense, covering MHC antigen
presentation, hypersensitivity reactions, TCR diversity, complement system, TLRs, somatic
hypermutation, flow cytometry, immune checkpoints, NK cells, class switching, ELISA,
Tregs, cytokine storm, and APC function; (4) Microbiology and Infectious Diseases,
addressing Gram staining, antibiotic resistance, qPCR diagnostics, biofilms, viral load
monitoring, MALDI-TOF MS, multiplex panels, AST, metagenomics, blood cultures, fungal
diagnostics, rapid antigen testing, WGS, and antimicrobial stewardship; (5) Biochemistry
and Enzymology, encompassing Michaelis-Menten kinetics, allosteric regulation, enzyme
inhibitors, clinical enzymology, post-translational modifications, Henderson-Hasselbalch
equation, isoenzymes, urea cycle, ELISA enzymes, lipid metabolism, HbA1c, P/O ratio,
proteomics, and tumor markers; (6) Biotechnology and Laboratory Techniques, covering
Western blotting, IHC, cell culture, NGS library preparation, liquid biopsy, bioinformatics,
companion diagnostics, digital pathology, quality control, TMA, single-cell sequencing, CISH,
3D bioprinting, and LIS; and (7) Research Methodology and Data Analysis, addressing RCTs,
p-values, sensitivity, specificity, ROC curves, Kaplan-Meier analysis, PPV, meta-analysis,
Bland-Altman plots, IRB, regression analysis, publication bias, Cohen's kappa, assay
validation, and GLP standards. Each of the 100 questions is mapped to a distinct sub-topic,
ensuring thorough, non-overlapping coverage. Mastery demonstrates professional
readiness for competent biomedical research and diagnostic laboratory execution.
Question 1: During DNA replication, the enzyme responsible for unwinding the double
helix at the replication fork is:
, A. Topoisomerase
B. Helicase — which breaks the hydrogen bonds between complementary base
pairs, separating the two parental strands to serve as templates for new strand
synthesis
C. DNA polymerase III
D. Ligase
Correct Answer: B. Helicase — which breaks the hydrogen bonds between
complementary base pairs, separating the two parental strands to serve as templates
for new strand synthesis
Rationale: Helicase unwinds the double helix. DNA polymerase III (A) synthesizes the new
strand. Ligase (C) joins Okazaki fragments. Topoisomerase (D) relieves supercoiling ahead
of the fork.
Question 2: The Central Dogma of molecular biology describes the flow of genetic
information as:
A. DNA → RNA → Protein, with DNA being transcribed into mRNA, which is then
translated into protein at the ribosome
B. Protein → DNA → RNA
C. RNA → DNA → Protein
D. Protein → RNA → DNA
Correct Answer: A. DNA → RNA → Protein, with DNA being transcribed into mRNA,
which is then translated into protein at the ribosome
Rationale: The Central Dogma flows from DNA to RNA to protein. Reversed flows (A, B, D)
do not represent the standard dogma, though reverse transcription (RNA→DNA) is an
exception via retroviruses.
Question 3: A missense mutation results in:
A. A single nucleotide substitution that changes one amino acid to a different
amino acid in the polypeptide, potentially altering protein structure and function
— as seen in the sickle cell hemoglobin (HbS) mutation (Glu→Val at position 6 of
the beta-globin chain)
B. No change in the amino acid sequence due to codon degeneracy
, C. Insertion of multiple nucleotides causing a frameshift
D. A premature stop codon truncating the protein
Correct Answer: A. A single nucleotide substitution that changes one amino acid to a
different amino acid in the polypeptide, potentially altering protein structure and
function — as seen in the sickle cell hemoglobin (HbS) mutation (Glu→Val at position
6 of the beta-globin chain)
Rationale: Missense mutations change one amino acid. No change (A) describes a silent
mutation. Premature stop (B) is a nonsense mutation. Multiple insertions with frameshift
(D) are frameshift mutations.
Question 4: Polymerase chain reaction (PCR) amplifies a specific DNA target sequence
using which three temperature-dependent steps in each cycle?
A. Denaturation (94-98°C to separate double-stranded DNA), annealing (50-65°C
for primer binding to template), and extension (72°C for Taq polymerase to
synthesize new DNA strands)
B. Centrifugation, filtration, and electrophoresis
C. Transcription, translation, and replication
D. Ligation, phosphorylation, and methylation
Correct Answer: A. Denaturation (94-98°C to separate double-stranded DNA),
annealing (50-65°C for primer binding to template), and extension (72°C for Taq
polymerase to synthesize new DNA strands)
Rationale: PCR cycles through denaturation, annealing, and extension.
Ligation/phosphorylation/methylation (A) are other molecular processes.
Transcription/translation/replication (C) are cellular processes.
Centrifugation/filtration/electrophoresis (D) are separation techniques.
Question 5: Epigenetic modifications that regulate gene expression WITHOUT altering the
DNA nucleotide sequence include:
A. Chromosomal translocations and inversions
B. Base pair substitutions and insertions
C. Point mutations and chromosomal deletions
, D. DNA methylation (typically at CpG dinucleotides) and histone modifications
(acetylation, methylation, phosphorylation) that alter chromatin accessibility
and transcription factor binding
Correct Answer: D. DNA methylation (typically at CpG dinucleotides) and histone
modifications (acetylation, methylation, phosphorylation) that alter chromatin
accessibility and transcription factor binding
Rationale: DNA methylation and histone modifications are epigenetic. Point mutations (A),
translocations (C), and substitutions (D) all alter the DNA sequence, making them genetic,
not epigenetic.
Question 6: Alternative splicing of pre-mRNA allows:
A. Direct translation of DNA without any RNA intermediate
B. Only one protein product per gene under all circumstances
C. A single gene to produce multiple different mRNA variants and therefore
multiple distinct protein isoforms by selectively including or excluding specific
exons during mRNA processing — greatly expanding the proteome beyond the
number of genes in the genome
D. Only the removal of exons while retaining all introns in the mature mRNA
Correct Answer: C. A single gene to produce multiple different mRNA variants and
therefore multiple distinct protein isoforms by selectively including or excluding
specific exons during mRNA processing — greatly expanding the proteome beyond
the number of genes in the genome
Rationale: Alternative splicing generates protein diversity. One protein per gene (A)
ignores this mechanism. Direct DNA translation (C) does not occur in eukaryotes. Exon
removal with intron retention (D) reverses the splicing process.
Question 7: Tumor suppressor gene TP53 encodes the p53 protein, which functions as a
'guardian of the genome' by:
A. Stimulating angiogenesis to supply nutrients to rapidly dividing cells
B. Enhancing telomerase activity to promote cell immortality
C. Promoting uncontrolled cell proliferation and inhibiting apoptosis